CPIX News and Press, Cumberland Pharmaceuticals Inc. From 02/17/26

2026-02-17 09:40:38 ET Short sellers are largely absent from a group of small- and mid-cap stocks where short interest hovers around just 0.5%, signaling limited bearish conviction across a diverse mix of sectors.... Read the full article on Seeking Alpha For further details see...

Cumberland Pharmaceuticals Receives FDA Fast Track Designation for its Ifetroban Duchenne Muscular Dystrophy Program PR Newswire NASHVILLE, Tenn. , Feb. 4, 2026 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX) , a specialty pharmaceutical company focused o...

2026-01-05 16:15:00 ET Today's pharmaceutical stocks are facing the challenges of government-imposed drug price caps, waning demand for COVID-19 vaccines and global stock market upheaval. However, the industry's major underlying drivers — higher rates of cancer and chronic di...

CALDOLOR® (IBUPROFEN) INJECTION CMS ISSUED J-CODE NOW ASSOCIATED WITH REIMBURSEMENT PRICE SUPPORTING NON-OPIOID PAIN MANAGEMENT PR Newswire NASHVILLE, Tenn. , Dec. 8, 2025 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), today announced an important upda...

2025-11-04 18:06:59 ET More on Cumberland Pharmaceuticals Cumberland Pharmaceuticals Inc. (CPIX) Q3 2025 Earnings Call Transcript Seeking Alpha’s Quant Rating on Cumberland Pharmaceuticals Financial information for Cumberland Pharmaceuticals Read the...

2025-11-04 18:06:29 ET Cumberland Pharmaceuticals Inc. (CPIX) Q3 2025 Earnings Call November 4, 2025 4:30 PM EST... Read the full article on Seeking Alpha For further details see: Cumberland Pharmaceuticals Inc. (CPIX) Q3 2025 Earnings Call Transcript

2025-11-04 17:24:46 ET More on Cumberland Pharmaceuticals Seeking Alpha’s Quant Rating on Cumberland Pharmaceuticals Financial information for Cumberland Pharmaceuticals Read the full article on Seeking Alpha For further details see: Cumberland Pha...

CUMBERLAND PHARMACEUTICALS REPORTS 12% YEAR-TO-DATE REVENUE GROWTH PR Newswire NASHVILLE, Tenn. , Nov. 4, 2025 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX) , a specialty pharmaceutical company, announced today that its product portfolio of FDA-approved bran...

CUMBERLAND PHARMACEUTICALS TO ANNOUNCE Q3 2025 FINANCIAL RESULTS & COMPANY UPDATE CUMBERLAND PHARMACEUTICALS TO ANNOUNCE Q3 2025 FINANCIAL RESULTS & COMPANY UPDATE PR Newswire NASHVILLE, Tenn. , Oct. 28, 2025 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (Nasdaq:...

CUMBERLAND PHAMACEUTICALS ANNOUNCES THE ADDITION OF AN ESTABLISHED FDA APPROVED PRODUCT TO ITS COMMERCIAL PORTFOLIO PR Newswire  Cumberland to expand its gastroenterology offerings with the market-leading Helicobacter pylori therapy NASHVILLE, Tenn. , Oct. 20, 2025 ...